Clinical Trial Update: Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating rosuvastatin’s effect on reducing coronary atherosclerosis plaque volume in patients with hyperlipidemia and Coronary A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Hyperlipidemia

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Peking University First Hospital | Conditions: Hyperlipidemia, Coronary Artery Disease | Phase 4 | Status: UNKNOWN